Anupama Kumar
@anupamakumar05
Followers
72
Following
92
Media
1
Statuses
13
RT @GreatDebatesCME: 🩸 Inside Insights | Expert commentary from a leading clinician in hematologic malignancies. We asked Dr. Anupama Ku….
0
1
0
RT @GreatDebatesCME: 🩸 Inside Insights | Expert commentary from a leading clinician in hematologic malignancies. We asked Dr. Andrew Cowan….
0
3
0
RT @RahulBanerjeeMD: Looking forward to this! We don't talk enough about palliative care co-management in myeloma, but it will be front & c….
0
4
0
RT @AjaiChari: Delayed cart neurotox -likely 4 risk factors demographics, disease burden, high grade crs/icans, peak CAR expansion. However….
0
11
0
RT @AjaiChari: @MeeraMohanMD @Hemobuddy Adding first author @anupamakumar05 to provide some clarity.
0
1
0
RT @ninashah33: Cinco de Myeloma (observed)! ! Love celebrating with my @UCSFCancer family! @SandyWong02111 @AjaiChari @TomBmt133 @myelomaw….
0
7
0
RT @drkomanduri: Now at @UCSFDOM Grand Rounds @AjaiChari discussing the vexing problem of Parkinsonism arising after BCMA-targeted CAR-T th….
0
5
0
RT @apwiita: New preprint‼️ While BCMA #CART are amazing for #myeloma, pts with high-risk disease relapse sooner. We show CD70 is a novel C….
biorxiv.org
Despite the success of BCMA-targeting CAR-Ts in multiple myeloma, patients with high-risk cytogenetic features still relapse most quickly and are in urgent need of additional therapeutic options....
0
25
0
RT @TomBmt133: Please join us in welcoming our newest member of the UCSF Myeloma Team - Dr. Anupama Kumar - with interests in CART and bisp….
0
3
0